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Abstract The anion exchange protein AE1 is the most abundant
membrane protein in human erythrocytes mediating the electro-
neutral chloride/bicarbonate exchange. We identified a promoter
region in the 5P flanking region of the human AE1 gene which
controls transcription in a cell type independent manner. In
addition a second, distal promoter element mediates gene
expression only in erythroid cells and in dependence upon
differentiation. Within this distal promoter region we defined a
44 bp sequence containing a novel CT-rich motif with very strong
promoter activity whereas a second 28 bp segment suppresses
gene expression.
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1. Introduction
The anion exchange protein 1 (AE1, band 3) is the major
integral membrane protein of erythrocytes. It functions as an
electroneutral reversible exchanger of bicarbonate for chloride
facilitating removal of carbon dioxide and increasing the car-
bon dioxide capacity of blood. Additionally, AE1 is thought
to be involved in membrane-cytoskeletal interaction and the
assembly of the membrane skeleton (for review see [1^3]).
AE1 de¢cient mice [4,5] develop spherocytosis and severe he-
molytic anemia probably due to the enhanced removal of
abnormally shaped erythrocytes by the spleen.
AE1 belongs to the family of anion exchangers of which at
least three members (AE1^3) have been identi¢ed by cDNA
cloning from di¡erent species and tissues (for review see
[2,6,7]). The human AE1 cDNA has been cloned from a fetal
liver cDNA library [8,9] and has been mapped to chromosome
17 [10]. In chicken erythroid precursor cells four variant AE1
proteins are expressed which are encoded by a total of 14 AE1
transcripts with di¡erent translation initiation sites [11].
Twelve of these transcripts are derived from two di¡erent
erythroid speci¢c promoters P1 and P2 which are located
immediately upstream of the transcription start sites. Within
these promoter regions the chicken AE1 gene contains typical
homologs of presumptive TATA, Sp1, Ap1, Ap2 and CCAAT
binding sites [12]. The expression of two further transcripts
which are abundant in both chicken erythrocytes and kidney
cells is regulated by the promoter P3 [11].
Similar to the chicken gene, AE1 expression in mammals is
not restricted to erythroid cells but is also found in human
brain [13]. An amino-terminal truncated version of AE1 exists
in renal intercalated cells of the A type. In rat the 5P end of
renal AE1 mRNA could be mapped to intron 3 suggesting an
alternative promoter within this intron [14]. In human kidney
a truncated AE1 primary transcript is alternatively spliced
leading to mRNA in which methionine 66 is used as trans-
lation initiation codon [15]. It has been shown for the mouse
gene that a renal speci¢c promoter located within intron 3 is
responsible for the expression of the truncated renal protein
and that this promoter is not active in erythroid cells at di¡er-
ent stages of erythroid di¡erentiation [16]. Within intron 3
potential TATA sequences located downstream of a cluster
of putative transcription factor binding sites could be detected
in the mouse gene [17] as well as in the human gene [18]. In
contrast to the avian gene such TATA sequences are missing
in the 5P £anking region of mammalian AE1 genes [14,17^19].
As expected for a TATA-less promoter the AE1 transcription
initiation sites of erythroid AE1 mRNA are heterogeneous
and have been mapped in Friend murine erythroleukemic cells
to ¢ve clustered sites upstream of the translation initiation
codon [19]. A basal promoter activity of a 135 bp region
immediately 5P £anking the mouse AE1 gene could be de-
tected in erythroid and non-erythroid cells [16]. An additional
200 nucleotides were required to obtain induced promoter
activity in di¡erentiating erythroid cells.
As a ¢rst approach towards understanding the molecular
regulation of the erythroid expression of the human AE1
gene, we isolated the 5P £anking region and monitored pro-
moter activity of di¡erent fragments by reporter gene expres-
sion. In addition to a cell type independent proximal pro-
moter, we detected a second promoter region, located more
upstream, which confers cell type and di¡erentiation speci¢c
gene expression. Within this region we de¢ned a CT-rich se-
quence with strong promoter activity as well as putative re-
pressor protein binding sites.
2. Materials and methods
2.1. Isolation of the human AE1 gene 5P £anking sequence and
construction of reporter plasmids
A human genomic cosmid library cloned in pcos2EMBL was
screened with the complete K-32P-labeled AE1 cDNA. Positive clones
were characterized by restriction mapping and subsequent Southern
blot hybridization. A 5.5 kb fragment representing the 5P £anking
region of the human AE1 gene was identi¢ed by oligonucleotide hy-
bridization (position 3100 to 380 relative to the translation initiation
site). 1787 bp 5P to the translation initiation site were sequenced on
both strands using K[35S]dATP [20] and have been deposited in Gen-
Bank (accession number AJ011714). Appropriate restriction and PCR
ampli¢ed fragments as well as fragments derived from exonuclease
digestion of longer sequences were subcloned in front of the luciferase
gene in the pGL2-Basic reporter plasmid (Promega, Fig. 2,5,6).
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2.2. Cell lines and culture
K562 cells (ATCC CCL 243) were grown in RPMI 1640 supple-
mented with 10% fetal calf serum (Life Technologies), 2 mM L-gluta-
mine, 50 U/ml penicillin and 50 Wg/ml streptomycin at 37‡C and 5.5%
carbon dioxide. Hemin was added for induction of erythroid di¡er-
entiation at a ¢nal concentration of 35.5 WM. HeLa (ATCC CCL 2)
cells were grown in minimal essential medium containing 10% calf
serum, L-glutamine (2 mM), penicillin (50 U/ml) and streptomycin
(50 Wg/ml).
2.3. Quanti¢cation of AE1 transcription and hemoglobin synthesis
AE1 transcripts were quanti¢ed by reversed transcription based
polymerase chain reaction (RT-PCR) in combination with tempera-
ture gradient gel electrophoresis (TGGE) [21]. As an internal reference
for reverse transcription we used mutated AE1 copy RNA
(AAGCGCA, Lys539Ala). 4 Wg K562 total RNA, prepared at di¡er-
ent times after hemin treatment, was mixed with 106 copies of the
corresponding mutated copy RNA and were reverse transcribed using
primer oko10: 5P GCG GAT CCC TTC TGT AGT GGG TGG TCC
3P. Following ultra¢ltration (Centricon 100, Amicon), 1/10 of the
cDNA was used to amplify a 399 bp AE1 fragment with primers
oko9 (5P CGG GGA TCC GCT GGT GTT GTT TGA GGA
AGC C 3P) and oko10. As a standard for TGGE, the corresponding
AE1 fragment subcloned in pUC18 was excised and labeled with
K[32P]dCTP using Klenow polymerase. One tenth of the PCR reaction
was mixed with 20 000 cpm of the standard fragment. After denatu-
ration (5 min, 94‡C) and renaturation (30 min, 60‡C) homo- and
heteroduplexes were formed and separated by parallel TGGE in a
8% urea/5% polyacrylamide gel and a linear 20^60‡C temperature
gradient for 30 min. Homo- and heteroduplex DNA was detected
by autoradiography and quanti¢ed by liquid scintillation counting.
Hemoglobin of K562 cells was quanti¢ed as methemoglobin cyanide
(Merck).
2.4. Transfection and reporter gene analysis
CsCl puri¢ed recombinant plasmids were introduced in K562 cells
in complex with cationic liposomes (Lipofectin, Life Technologies).
Transfections of di¡erentiating K562 cells were performed by addition
of 35.5 WM hemin to the medium 36 h prior to transfection. 20 Wg
reporter gene plasmid was cotransfected with 10 Wg pCMV-L-gal as an
internal reference containing the prokaryotic L-galactosidase under
the control of the cytomegalovirus promoter. 3U106 cells were
washed twice in serum free medium and resuspended in 3 ml medium
containing 30 Wg lipofectin and 30 Wg plasmid DNA. Cells were in-
cubated for 6 h before addition of 6 ml of supplemented RPMI me-
dium. Cells were harvested 48 h post transfection when luciferase
activity was maximal. HeLa cells were transfected by calcium phos-
phate precipitation [22]. Luciferase activity was determined with the
luciferase assay system (Promega). Transfection e⁄ciency was stand-
ardized by measuring L-galactosidase activity using a chemilumines-
cent assay (Tropix). Luciferase activity was referred to the protein
level of the extracts and normalized by the exogenous galactosidase
activity.
2.5. Nuclear extract preparation
From untreated K562 cells and from cells that were previously
stimulated to di¡erentiation with hemin for 36 h nuclear proteins
were extracted and stored according to Osborn et al. [23]. Extracts
were successively puri¢ed and concentrated under non-denaturing
conditions by ultra¢ltration using ¢lter units with molecular cuto¡s
of 100, 30 and 10 kDa (Amicon). The protein concentration was
determined using bicinchoninic acid (Pierce). The fraction containing
proteins and protein complexes with a molecular mass s 100 000 was
used in DNase I footprint experiments and in gel mobility shift assays
unless stated otherwise. In some experiments we used nuclear extracts
¢ltered solely through a membrane with a molecular cuto¡ of 10 kDa.
2.6. DNase I footprinting
HindIII/KpnI fragments originating from di¡erent recombinant
pGL-Basic clones were selectively radiolabeled with Klenow polymer-
ase at the HindIII site and were used as a probe in DNase I footprint
experiments as described [24]. 15 fmol labeled DNA and 1.5 Wg poly-
[dI-dC]Wpoly[dI-dC] were incubated at 25‡C in the absence and pres-
ence of 5 Wg nuclear proteins isolated from hemin stimulated cells. 0,
0.625 and 1.25 ng DNase I were added for 2 min before the DNase
was inactivated by addition of EDTA, SDS and proteinase K fol-
lowed by phenol extraction and ethanol precipitation. The reaction
products were analyzed on a denaturing polyacrylamide gel. As refer-
ence we took reaction products obtained by Sanger sequencing with
primers of which the 5P end matched to the labeled end of the inves-
tigated fragment.
2.7. Band shift assay
0.5^5 fmol end labeled DNA was puri¢ed by gel electrophoresis and
incubated with di¡erent amounts of poly[dI-dC]Wpoly[dI-dC] in 42
mM NaCl, 20 mM KCl, 20 mM N-(2-hydroxyethyl)piperazine-N9-2-
ethanesulfonic acid (pH 7.9), 10 mM MgCl2, 5 mM CaCl2, 0.1 mM
EDTA, 0.25 mM phenylmethylsulfonyl £uoride and 2.5 mM dithio-
threitol. 5 Wg of nuclear proteins were added and the mixture was
incubated for 30 min at room temperature. The reaction mixtures
were applied on a 5% polyacrylamide (29:1) gel and separated at
4‡C and 4 V/cm as described [25]. For the analysis of double stranded
oligonucleotides, 0.5 pmol of complementary single stranded oligonu-
cleotides (Fig. 3c) were denatured in 20 Wl 50 mM Tris (pH 7.5),
10 mM MgCl2, 1 mM dithiothreitol and 50 Wg/ml BSA for 15 min
at 80‡C and annealed at room temperature overnight followed by
radioactive labeling of speci¢c nucleotide overhangs using Klenow
polymerase.
3. Results
3.1. Two regulatory regions with di¡erent cell type speci¢city
To identify sequences responsible for AE1 expression, we
cloned a 5.5 kb DNA fragment encoding the 5P £anking re-
gion of the human AE1 gene. Comparison of 1787 bp 5P to
the translation initiation site (excluding the intron 1 sequence
at position 369) and 1710 bp of the mouse gene [19] revealed
conspicuous homology of the nucleotides 3170 to 3380 and
an accumulation of transcription factor binding sites within
the same region of both genes (data not shown) suggesting a
similar localization of the human and the mouse AE1 pro-
moter. In addition, we found another cluster of recognition
sites for transcription factors in the human gene between nu-
cleotides 31300 to 31700 which is missing in the mouse AE1
5P £anking region. To investigate the function of the putative
regulatory regions, we dissected the 5.5 kb fragment into three
parts which were cloned upstream of the luciferase reporter
gene (Fig. 1a). Luciferase activities of the recombinant con-
structs pGL-A, pGL-B and pGL-C were analyzed after trans-
fection of erythroleukemic K562 cells or epithelial HeLa cells
as a non-erythroid reference and compared with a control
plasmid containing the SV40 promoter (pGL-Control).
An enhanced luciferase activity was measured in transfec-
tions using the recombinant plasmid pGL-C indicating that
the AE1 promoter is located within this 1041 bp fragment.
This corresponds to the promoter localization directly 5P to
the transcription initiation sites reported for the mouse AE1
gene [16]. Reporter gene expression was similar in both K562
and HeLa cells showing a cell type independent promoter
activity. In addition, we found that a more distantly located
region B comprising a second cluster of transcription factor
binding sites (pGL-B) mediates gene expression independently
of the proximal AE1 promoter. Plasmid pGL-B led to a sig-
ni¢cant increase of reporter gene expression in K562, but in
contrast to expression levels obtained with the proximal pro-
moter (pGL-C), pGL-B did not mediate gene expression in
HeLa cells. This indicates a cell type speci¢c activity of this
additional, independent promoter element. We further dis-
sected fragment B into two parts B1 (31787 to 31497) and
B2 (31496 to 31122) and compared their potency upon gene
expression to the other fragments. Subsequent transfection
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experiments identi¢ed fragment B2 as functionally active with
a relative expression rate of 12.2%. Based on these results, we
designated fragment B2 the regulatory region B2 (RRB2).
RRB2 possesses an independent regulatory activity which
should be due to protein binding of speci¢c transcription fac-
tors within RRB2. Therefore, we performed band shift experi-
ments using the radio-labeled RRB2 fragment. As shown in
Fig. 1, K562 nuclear proteins bind indeed speci¢cally within
RRB2 as seen by the formation of shifting DNA/protein com-
plexes in the presence of increasing amounts of unspeci¢c
competitor DNA (Fig. 1b) and as seen by the competition
of such complexes by the addition of a 50^100-fold excess
of unlabeled RRB2 fragment (Fig. 1c).
3.2. Changes of promoter activity during erythroid
di¡erentiation
In a next series of experiments, we looked for the potential
role of the di¡erent AE1 promoter regions upon enhanced
AE1 expression during red blood cell maturation. We inves-
tigated changes of the AE1 promoter activity during erythroid
di¡erentiation by quanti¢cation of AE1 gene transcription in
K562 cells which had been induced to di¡erentiate with hemin
(Fig. 2a). In parallel we measured the production of hemoglo-
bin serving as a marker of di¡erentiation [26]. Upon treatment
of K562 cells with hemin, hemoglobin increased more than
2.5-fold from an initial value of 1.3 pg/cell to a maximum of
3.4 pg/cell after 96 h and decreased slightly after 5 days. In
parallel to the proceeding erythroid di¡erentiation the AE1
mRNA level rose about 2-fold from three copies/cell to six
copies/cell (100%) after 36 h and decreased after 72 h to basal
transcription indicating that enhanced AE1 promoter activity
is linked to red blood cell maturation.
Therefore, we examined changes of AE1 promoter activity
during erythroid di¡erentiation by transfection of reporter
plasmids in non-stimulated K562 cells and cells which were
stimulated to di¡erentiation with hemin for 36 h (Fig. 2b).
Treatment of the cells with hemin signi¢cantly decreased
SV40 promoter dependent expression of the reporter gene
making the pGL-Control plasmid unsuitable as a reference
for this study (data not shown). However, we detected in-
creased luciferase activity in hemin stimulated cells when
AE1 promoter constructs (pGL-B, pGL-C) were transfected,
indicating that the investigated 5P £anking sequences control
genes expression in dependence of di¡erentiation. This e¡ect
was most signi¢cant after transfection of pGL-B with a more
than 3-fold enhancement of luciferase activity in contrast to
pGL-C transfections which showed only a slight increase of
the basal gene expression. Thus, region B contains not only a
cell speci¢c but also a di¡erentiation dependent promoter el-
ement RRB2.
To further support this ¢nding, we investigated if this dif-
ferentiation speci¢c enhancement is re£ected by changes of the
interaction properties of AE1 promoter sequences to nuclear
proteins. Nuclear extracts from undi¡erentiated and from
hemin stimulated K562 cells were each ¢ltered through mem-
branes with di¡erent molecular cuto¡s to pool proteins with
similar molecular mass which were subsequently analyzed for
their interaction with RRB2 in band shift assays. As shown in
Fig. 2c, we found RRB2 binding proteins enriched in fractions
of proteins or protein complexes with a molecular mass higher
than 100 000. Three di¡erent bands could be detected leading
to the conclusion that several sites of protein interaction exist
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Fig. 1. Independent AE1 promoter elements with di¡erent cell type
speci¢city. a: Luciferase activity in cell extracts obtained 48 h post
transfection of K562 cells (gray columns) and HeLa cells (black col-
umns) with di¡erent recombinant reporter plasmids referred to
SV40 promoter mediated luciferase expression (pGL-Control,
100%). The length of the inserted fragments and distances to the
AE1 translation start excluding intron 1 is indicated. Values repre-
sent mean þ S.D. of three independent experiments (n = 5). b: Band
shift assay of 1 ng K-32P-labeled RRB2 fragment in the presence (+)
or absence (3) of 5 Wg nuclear extract (molecular mass s 10 000)
and in the presence of increasing amounts (0^4 Wg) of poly[dI-
dC]Wpoly[dI-dC]. c: Competition of speci¢c interaction of RRB2 to
nuclear proteins in a band shift assay by addition of a increasing
amounts of unlabeled RRB2 fragment (0^200-fold excess) in the
presence of 2 Wg poly[dI-dC]Wpoly[dI-dC]. Speci¢c DNA/protein
complexes are marked by arrows.
S. Philipp et al./FEBS Letters 438 (1998) 315^320 317
in RRB2. Remarkably, we detected changes in the band pat-
tern using nuclear extracts from hemin treated cells indicating
that the assembly of RRB2/protein complexes might be
changed upon erythroid di¡erentiation and probably re£ect-
ing enhanced promoter activity during red blood cell matura-
tion.
3.3. Elements enhancing and silencing gene expression are
located within RRB2
To de¢ne distinct base pairs within RRB2 which contribute
to AE1 transcription, we ¢rst dissected this region into ¢ve
smaller parts B3^B7 (Fig. 3a) and analyzed their promoter
activity upon luciferase expression. 122 bp in the upstream
part of RRB2 had no promoter activity (pGL-B7) but remov-
al of this sequence (pGL-B4) resulted in a signi¢cant enhance-
ment of luciferase activity which was even higher than SV40
driven reporter gene expression. The absence of nucleotides
31374 to 31331 decreased luciferase activity to background
levels (pGL-B5) indicating that this 44 bp stretch is respon-
sible for a strong expression of genes located downstream. We
de¢ned this 44 bp sequence as a distal activator segment
(DAS). The upstream nucleotides 31375 to 31402 of DAS
reduced activity (pGL-B3) to similar levels as detected in case
of RRB2 (pGL-B2) leading to the conclusion that a distal
silencer segment (DSS) is located within this 28 bp region.
Removal of the downstream part of RRB2 (nucleotides
31122 to 31285, pGL-B6) led to enhanced luciferase activity
suggesting the existence of additional silencing elements with-
in this region. Inversion of the orientation of RRB2 (pGL-
B2rev) or fragment B6 (pGL-B6rev) in relation to the lucifer-
ase gene resulted in a 2^3-fold reduction but not in a complete
absence of transcription activity indicating that RRB2 func-
tion is dependent upon its orientation.
Based on the results of the reporter gene analysis, it can be
expected that DAS and DSS contain transcription factor
binding sites for activator and suppressor proteins. We tested
this idea by footprint analysis of RRB2 (Fig. 3b) and band
shift assays (Fig. 3c). Indeed, we detected two footprints with-
in DAS corresponding to nucleotides 31353 to 31343
(TTTTCTCTCTC) and to nucleotides 31365 to 31362
(GTGT) indicating that these novel protein binding sites in-
teract with sequence speci¢c transcription factors responsible
for AE1 transcription mediated by DAS. The motif
TTTTCTCTCTC is unique in the 5P £anking region of the
AE1 gene and consists exclusively of pyrimidines conferring
an extreme purine/pyrimidine asymmetry to the double
stranded DNA.
In addition, three protein binding motifs were present with-
in DSS. For one of them nucleotides involved in protein bind-
ing were slightly di¡erent on the coding and non-coding
strand probably re£ecting asymmetrical DNA binding. The
other two motifs were de¢ned as CATAAAC (nucleotides
31392 to 31386) and as GATTCTGCCT (nucleotides
31383 to 31374). It seems likely that these motifs bind to
repressor proteins.
We con¢rmed protein binding to DAS and DSS by band
shift experiments (Fig. 3c) using double stranded oligonucleo-
tides corresponding in their sequence to the footprint areas
within DAS (oligoDAS) and DSS (oligoDSS). Investigation of
oligoDSS revealed three bands corresponding to DNA/protein
complexes indicating that di¡erent kinds of proteins bind to
this oligonucleotide. Similarly, investigation of oligoDAS led
to the appearance of three bands in the shift experiment. In
one case, DNA/protein binding was stable even in the pres-
ence of the highest amounts of competitor used, showing that
protein binding within DAS is stronger than in DSS. We
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Fig. 2. Enhancement of AE1 expression and AE1 promoter activity
during erythroid di¡erentiation. a: Time course of AE1 mRNA
(squares) and hemoglobin (circles) formation following induction of
K562 cell di¡erentiation with hemin. All values are given as percent-
age of maximum values (AE1 mRNA 6.05 copies/cell ; hemoglobin
3.4 pg/cell) as mean of two independent experiments (n = 3). b: Re-
porter gene expression mediated by AE1 5P £anking fragments in
extracts of untreated (black columns) and 36 h hemin treated (gray
columns) K562 cells. The length of the fragments and their relative
position to the AE1 translation start site excluding intron 1 is indi-
cated by numbers. Values represent mean of two experiments
(n = 5). c: Gel retardation assay of 1 ng labeled RRB2 fragment in
the presence of 2 Wg nuclear proteins/protein complexes of di¡erent
molecular mass obtained from untreated and 36 h hemin treated
K562 cells and in the presence of 2 Wg poly[dI-dC]Wpoly[dI-dC]. In a
control reaction, nuclear proteins were substituted by 10 Wg bovine
serum albumin (BSA). Speci¢c DNA/protein complexes are indi-
cated by arrows.
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conclude that DAS and DSS are cis-acting binding sites for
transcription factors which may be involved in tissue and
di¡erentiation dependent regulation of the AE1 gene.
4. Discussion
Sequence analysis of the 5P £anking region of the human
and the mouse AE1 gene shows striking sequence similarity
about 400 nucleotides upstream of the translation initiation
site. Within this region multiple putative transcription factor
binding sites are located [17,18] and transcription is initiated
at di¡erent start sites in the rat and mouse genes [14,19]. In
this study we provide evidence that the promoter of the hu-
man AE1 gene is in a similar location as in the rat and mouse
genes. This proximal promoter regulates expression in a cell
type independent manner since it is active in epithelial cells
which were not expected to express AE1. This result corre-
sponds to that obtained for the mouse AE1 promoter [16]
which is active in Rauscher erythroleukemic cells as well as
in ¢broblasts (NIH3T3). We conclude that additional regula-
tory sequences exist which might confer cell type speci¢c AE1
expression in erythroid cells. Similar to the chicken AE1 gene,
we could show that a second promoter exists which is located
far upstream of the proximal promoter. Within this distal
element, called RRB2, a similar accumulation of putative
transcription factor binding sites is located. In contrast to
the proximal promoter, RRB2 is active only in K562 cells
indicating that RRB2 activity might be restricted to erythroid
cells and may re£ect its cell type speci¢city. Although RRB2 is
able to mediate reporter gene expression in vitro, its function
and cooperation with the downstream promoter in vivo is
elusive. Further studies will show, if both regulatory regions
are active in vivo and how they might work together.
To investigate a possible role for regulatory elements during
erythroid di¡erentiation, we chose the human cell line K562.
These cells transcribe the AE1 gene in dependence upon the
erythroid di¡erentiation suggesting a coordinated regulatory
mechanism. Both regulatory elements are more active in dif-
ferentiating cells but the e¡ect is more signi¢cant with the
distal promoter RRB2. It seems possible that erythroid spe-
ci¢c transcription factors like GATA and NF-E2 contribute
to the enhanced AE1 expression during red blood cell matu-
ration since GATA binding sites are located within both reg-
ulatory regions. Those factors may coordinate expression of
several genes like AE1 and hemoglobin during red blood cell
maturation [27^29].
A closer examination of the distal element RRB2 led to the
detection of a 44 bp region which serves as a promoter in
reporter gene assays even stronger as the viral SV40 promoter.
This DAS is characterized by strong interaction to nuclear
proteins and the existence of a purine/pyrimidine asymmetry
within an 18 bp stretch consisting exclusively of pyrimidines.
This novel CT-rich motif is unique in the 5P £anking region of
the human AE1 gene and might be involved in the formation
of a intramolecular triplex/single stranded DNA conformer
called H-DNA [30]. H-DNA conformers are abundant in
DNase I hypersensitive sites and might break chromatin struc-
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Fig. 3. Enhancer and silencer elements located within the distal pro-
moter region RRB2. a: Luciferase activity of K562 cell extracts ob-
tained after transient expression of reporter plasmids containing dif-
ferent fragments of RRB2 (pGL-B2) and referred to SV40 promoter
activity (pGL-Control, 100%). The length of the analyzed fragments
and their relative position to the AE1 translation start site excluding
intron 1 are indicated. ‘Rev’ indicates an inverted orientation of the
fragment relative to the reporter gene. Values represent
means þ S.D. (n = 3) of three independent experiments. b: DNase I
footprint analysis of the regulatory region B2. Digestion was per-
formed with 0 (1), 0.625 (2) and 1.25 (3) ng DNase I in the absence
(3) or presence (+) of nuclear proteins. Even in the absence of
DNase I (lane 1), DNA was hydrolysed when nuclear proteins were
present (+) indicating endogenous DNase activity of the nuclear ex-
tract. Reference lanes of sequencing reactions indicate the positions
of the footprints relative to the AE1 translation initiation site ex-
cluding intron 1. Brackets with numbers indicate footprint regions
of which oligonucleotides were deduced used in band shift assays
(c). c: Gel retardation assay of oligonucleotides corresponding to
footprint areas. Capital letters in the nucleotide sequence correspond
to the footprinted nucleotides. 10 pg (0.5 pmol) of double stranded
oligonucleotides was incubated in the presence (+) or absence (3)
of K562 nuclear proteins with increasing amounts of poly[dI-dC]Wpo-
ly[dI-dC]. Shifted DNA/protein complexes are indicated by arrows.
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tures to facilitate transcription. For the c-myc gene it has been
shown that a CT-rich motif is responsible for approximately
80% of the promoter activity [31]. In addition to sequences in
DAS, we could de¢ne DSSs in the neighborhood of DAS
which reduce promoter activity of RRB2.
The identi¢cation of the protein binding motifs DSS and
DAS provides the molecular basis for the identi¢cation of
transcription factors involved in regulation of AE1 gene ex-
pression. A closer examination of the tissue speci¢city of DAS
will reveal if this element may serve as a tissue speci¢c pro-
moter in gene targeting experiments or in gene therapy.
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